{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T11:09:42Z","timestamp":1762254582564,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jcv.2023.105549","type":"journal-article","created":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T12:17:43Z","timestamp":1689682663000},"page":"105549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Epidemiology of cytomegalovirus antiviral resistance testing for solid organ and bone marrow transplant patients from 2011 \u2013 2019"],"prefix":"10.1016","volume":"166","author":[{"given":"Lynne","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher F.","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"McLachlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc G.","family":"Romney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alissa","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4158-6955","authenticated-orcid":false,"given":"Nancy","family":"Matic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2023.105549_bib0001","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jcv.2007.11.014","article-title":"Human cytomegalovirus: latency and reactivation in the myeloid lineage","volume":"41","author":"Sinclair","year":"2008","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2023.105549_bib0002","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/cid\/cix259","article-title":"Risk factors and outcomes of ganciclovir-resistant cytomegalovirus infection in solid organ transplant recipients","volume":"65","author":"Fisher","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jcv.2023.105549_bib0003","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1016\/j.transproceed.2018.02.091","article-title":"Resistant cytomegalovirus infection in solid-organ transplantation: single-center experience, literature review of risk factors, and proposed preventive strategies","volume":"50","author":"Majeed","year":"2018","journal-title":"Transpl. Proc."},{"key":"10.1016\/j.jcv.2023.105549_bib0004","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1016\/j.transproceed.2018.08.009","article-title":"Risk factors for the development of cytomegalovirus resistance in solid organ transplantation: a retrospective case-control study","volume":"50","author":"Sandkovsky","year":"2018","journal-title":"Transpl. Proc."},{"key":"10.1016\/j.jcv.2023.105549_bib0005","unstructured":"Leukemia\/Bone Marrow Transplant Program. Available online: https:\/\/hematology.med.ubc.ca\/clinical-services\/lbmt\/ (accessed on November 22, 2022)."},{"key":"10.1016\/j.jcv.2023.105549_bib0006","unstructured":"2021 Organ Donation and Transplantation Summary. Available online: http:\/\/www.transplant.bc.ca\/Documents\/Statistics\/2021-BC-Organ-Donation-Transplant-Summary.pdf (accessed on November 22, 2022)."},{"key":"10.1016\/j.jcv.2023.105549_bib0007","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/TP.0000000000002191","article-title":"The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"102","author":"Kotton","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.jcv.2023.105549_bib0008","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/jmv.25189","article-title":"Transitioning cytomegalovirus viral load testing from a laboratory developed test to the cobas(\u00ae) CMV quantitative nucleic acid assay","volume":"90","author":"Payne","year":"2018","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jcv.2023.105549_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105123","article-title":"Next-generation sequencing for cytomegalovirus antiviral resistance genotyping in a clinical virology laboratory","volume":"192","author":"Chorlton","year":"2021","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jcv.2023.105549_bib0010","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1182\/blood.V97.4.867","article-title":"Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes","volume":"97","author":"Nichols","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jcv.2023.105549_bib0011","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/CMR.00009-10","article-title":"Antiviral drug resistance of human cytomegalovirus","volume":"23","author":"Lurain","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jcv.2023.105549_bib0012","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1128\/JCM.40.11.4105-4113.2002","article-title":"Human cytomegalovirus DNA in plasma and serum specimens of renal transplant recipients is highly fragmented","volume":"40","author":"Boom","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2023.105549_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219701","article-title":"Improvement in detecting cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance using next generation sequencing","volume":"14","author":"Lopez-Aladid","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcv.2023.105549_bib0014","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1053\/j.ajkd.2005.02.010","article-title":"Antiviral drug-induced nephrotoxicity","volume":"45","author":"Izzedine","year":"2005","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jcv.2023.105549_bib0015","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/jac\/dkq368","article-title":"Drug-resistant cytomegalovirus in transplant recipients: a French cohort study","volume":"65","author":"Hantz","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jcv.2023.105549_bib0016","unstructured":"BC Transplant, P.H.S.A. Medication guidelines for solid organ transplants. 2021."},{"key":"10.1016\/j.jcv.2023.105549_bib0017","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/sj.bmt.1705507","article-title":"Impact on the cytomegalovirus (CMV) viral load by CMV-specific T-cell immunity in recipients of allogeneic stem cell transplantation","volume":"38","author":"Avetisyan","year":"2006","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.jcv.2023.105549_bib0018","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/j.1600-6143.2009.02618.x","article-title":"Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients","volume":"9","author":"Kumar","year":"2009","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.jcv.2023.105549_bib0019","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s41669-021-00264-9","article-title":"Impact of letermovir use for cytomegalovirus prophylaxis on re-hospitalization following allogeneic hematopoietic stem cell transplantation: an analysis of a phase III randomized clinical trial","volume":"5","author":"Golan","year":"2021","journal-title":"Pharmacoecon. Open"},{"key":"10.1016\/j.jcv.2023.105549_bib0020","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcv.2023.105549_bib0021","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1128\/AAC.00186-10","article-title":"Recombinant phenotyping of cytomegalovirus UL97 kinase sequence variants for ganciclovir resistance","volume":"54","author":"Chou","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jcv.2023.105549_bib0022","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1086\/514041","article-title":"High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes","volume":"176","author":"Smith","year":"1997","journal-title":"J. Infect. Dis."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653223001725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653223001725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T03:17:50Z","timestamp":1761362270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653223001725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":22,"alternative-id":["S1386653223001725"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2023.105549","relation":{},"ISSN":["1386-6532"],"issn-type":[{"type":"print","value":"1386-6532"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology of cytomegalovirus antiviral resistance testing for solid organ and bone marrow transplant patients from 2011 \u2013 2019","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2023.105549","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105549"}}